APOE and coronary artery disorder: The CORDIOPREV trial from Spain highlighted the effects of APOE [18] and CLOCK gene [24] variants on lipid and inflammatory outcomes in coronary heart disease (CHD) patients following Mediterranean and low-fat diets (<30% of total calories).